Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-002586-34Phase 4Completed
Phase 4, randomised, double-blind trial in bowel obstruction and gastrointestinal perforation (GP) comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Change in plasma C-reactive protein. Started Jul 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-002586-34.